Your browser doesn't support javascript.
loading
Pirtobrutinib results in reversible platelet dysfunction compared to ibrutinib and acalabrutinib.
Bye, Alexander P; Kriek, Neline; Sage, Tanya; Rawlings, Suzannah J; Prodger, Catherine; Kesavan, Murali; Lees, Charlotte; Booth, Stephen; Cowen, Louise G; Shefferd, Kirsty; Desborough, Michael J; Gibbins, Jonathan M; Eyre, Toby A.
Afiliação
  • Bye AP; Molecular and Clinical Sciences Research Institute, St George's University, Cranmer Terrace, London, United Kingdom; Institute for Cardiovascular and Metabolic Research, School of Biological Sciences, University of Reading, Reading, RG6 6EX. a.bye@sgul.ac.uk.
  • Kriek N; Institute for Cardiovascular and Metabolic Research, School of Biological Sciences, University of Reading, Reading, RG6 6EX.
  • Sage T; Institute for Cardiovascular and Metabolic Research, School of Biological Sciences, University of Reading, Reading, RG6 6EX.
  • Rawlings SJ; Institute for Cardiovascular and Metabolic Research, School of Biological Sciences, University of Reading, Reading,.
  • Prodger C; Department of Clinical Haematology, Cancer and Haematology Centre, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, OX3 7LE.
  • Kesavan M; Department of Clinical Haematology, Cancer and Haematology Centre, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, OX3 7LE.
  • Lees C; Department of Clinical Haematology, Cancer and Haematology Centre, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, OX3 7LE.
  • Booth S; Department of Clinical Haematology, Royal Berkshire Hospital NHS Foundation Trust, Reading, RG1 5AN.
  • Cowen LG; Haematology Late Phase Clinical Trial Unit, Oxford University Hospitals NHS Foundation Trust, Oxford, OX3 7LE.
  • Shefferd K; Haematology Late Phase Clinical Trial Unit, Oxford University Hospitals NHS Foundation Trust, Oxford, OX3 7LE.
  • Desborough MJ; Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, OX3 7LE.
  • Gibbins JM; Institute for Cardiovascular and Metabolic Research, School of Biological Sciences, University of Reading, Reading, RG6 6EX.
  • Eyre TA; Department of Clinical Haematology, Cancer and Haematology Centre, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford,.
Haematologica ; 108(5): 1429-1435, 2023 05 01.
Article em En | MEDLINE | ID: mdl-36519322
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazinas / Leucemia Linfocítica Crônica de Células B Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazinas / Leucemia Linfocítica Crônica de Células B Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article